Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. · 2020
Read Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). by Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7318306.txt.
Description
Colunga Biancatelli and co-authors propose pairing quercetin, a plant flavonoid, with vitamin C as an experimental therapy against COVID-19. Their paper appeared in Frontiers in Immunology. Vitamin C supports immune function and has shown promise in the critically ill. Quercetin has antiviral properties studied in many settings, and vitamin C recycles it in the body, extending its action.
Given together, the two may exert a stronger combined antiviral and immune-calming effect than either alone. The authors present the evidence for using the pair to protect high-risk groups and as an add-on for patients alongside drugs such as remdesivir or convalescent plasma. Their argument is for priority testing: both substances are safe and cheap, with a sound biological rationale, in a pandemic short on proven treatments.
Catalog record
| CREATOR | Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |